Hosted on MSN

BD announces wearable injector trial for subcutaneous delivery of biologics

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas wearable injector for subcutaneous delivery of biologics. The decision to employ the injector in this first ...
Nasdaq

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
Odessa American

Global Wearable Patch Markets, Industry Analysis and Forecast, 2020-2026: Market Size Is Expected to Reach $12.6 Billion, Rising at a Growth Rate of 10.6% ...

The "Global Wearable Patch Market By Technology (Connected Wearable and Regular Wearable), By Application (Non-Clinical and Clinical), By Region, Industry Analysis and Forecast, 2020 – 2026" report ...